BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 35897686)

  • 1. Activation of Humoral Immunity during the Pathogenesis of Experimental Chronic Lung Allograft Dysfunction.
    Reichert M; Atanasova S; Petri K; Kampschulte M; Kojonazarov B; Fuchs-Moll G; Krombach GA; Padberg W; Grau V
    Int J Mol Sci; 2022 Jul; 23(15):. PubMed ID: 35897686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adaptive and innate immune responses in a rat orthotopic lung transplant model of chronic lung allograft dysfunction.
    Evers A; Atanasova S; Fuchs-Moll G; Petri K; Wilker S; Zakrzewicz A; Hirschburger M; Padberg W; Grau V
    Transpl Int; 2015 Jan; 28(1):95-107. PubMed ID: 25179205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A relevant experimental model for human bronchiolitis obliterans syndrome.
    Atanasova S; Hirschburger M; Jonigk D; Obert M; Petri K; Evers A; Hecker A; Schmitz J; Kaufmann A; Wilhelm J; Chakraborty T; Warnecke G; Gottlieb J; Padberg W; Grau V
    J Heart Lung Transplant; 2013 Nov; 32(11):1131-9. PubMed ID: 24050896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPS-induced Airway-centered Inflammation Leading to BOS-like Airway Remodeling Distinct From RAS-like Fibrosis in Rat Lung Transplantation.
    Takahagi A; Sato M; Chen-Yoshikawa TF; Miyamoto E; Saito M; Gochi F; Hamaji M; Yoshizawa A; Terasaki Y; Urushiyama H; Aoyama A; Sonobe M; Date H
    Transplantation; 2020 Jun; 104(6):1150-1158. PubMed ID: 31929420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spectrum of chronic lung allograft pathology in a mouse minor-mismatched orthotopic lung transplant model.
    Martinu T; Oishi H; Juvet SC; Cypel M; Liu M; Berry GJ; Hwang DM; Keshavjee S
    Am J Transplant; 2019 Jan; 19(1):247-258. PubMed ID: 30378739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The mitigating effect of exogenous carbon monoxide on chronic allograft rejection and fibrosis post-lung transplantation.
    Aoki Y; Walker NM; Misumi K; Mimura T; Vittal R; McLinden AP; Fitzgerald L; Combs MP; Lyu D; Osterholzer JJ; Pinsky DJ; Lama VN
    J Heart Lung Transplant; 2023 Mar; 42(3):317-326. PubMed ID: 36522238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Humoral immune responses mediate the development of a restrictive phenotype of chronic lung allograft dysfunction.
    Misumi K; Wheeler DS; Aoki Y; Combs MP; Braeuer RR; Higashikubo R; Li W; Kreisel D; Vittal R; Myers J; Lagstein A; Walker NM; Farver CF; Lama VN
    JCI Insight; 2020 Dec; 5(23):. PubMed ID: 33268593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-21 in Lung Transplant Recipients With Chronic Lung Allograft Dysfunction.
    Miyahara N; Benazzo A; Oberndorfer F; Iwasaki A; Laszlo V; Döme B; Hoda MA; Jaksch P; Klepetko W; Hoetzenecker K
    Transpl Int; 2021; 35():10184. PubMed ID: 35185369
    [No Abstract]   [Full Text] [Related]  

  • 9. The Lymphatic Phenotype of Lung Allografts in Patients With Bronchiolitis Obliterans Syndrome and Restrictive Allograft Syndrome.
    Traxler D; Schweiger T; Schwarz S; Schuster MM; Jaksch P; Lang G; Birner P; Klepetko W; Ankersmit HJ; Hoetzenecker K
    Transplantation; 2017 Feb; 101(2):310-315. PubMed ID: 27163544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of recipient derived interleukin-17A in a murine orthotopic lung transplant model of restrictive chronic lung allograft dysfunction.
    Yamada Y; Vandermeulen E; Heigl T; Somers J; Vaneylen A; Verleden SE; Bellon H; De Vleeschauwer S; Verbeken EK; Van Raemdonck DE; Vos R; Verleden GM; Jungraithmayr W; Vanaudenaerde BM
    Transpl Immunol; 2016 Nov; 39():10-17. PubMed ID: 27737799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leflunomide prolongs pulmonary allograft and xenograft survival.
    Yuh DD; Gandy KL; Morris RE; Hoyt G; Gutierrez J; Reitz BA; Robbins RC
    J Heart Lung Transplant; 1995; 14(6 Pt 1):1136-44. PubMed ID: 8719461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferret Lung Transplantation Models Differential Lymphoid Aggregate Morphology Between Restrictive and Obstructive Forms of Chronic Lung Allograft Dysfunction.
    Lynch TJ; Ahlers BA; Swatek AM; Ievlev V; Pai AC; Brooks L; Tang Y; Evans IA; Meyerholz DK; Engelhardt JF; Parekh KR
    Transplantation; 2022 Oct; 106(10):1974-1989. PubMed ID: 35442232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats.
    Tu ZL; Zhou ZY; Xu HC; Cao JL; Ye P; Wang LM; Lv W; Hu J
    J Cardiothorac Surg; 2017 May; 12(1):43. PubMed ID: 28545478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A B cell-dependent pathway drives chronic lung allograft rejection after ischemia-reperfusion injury in mice.
    Watanabe T; Martinu T; Chruscinski A; Boonstra K; Joe B; Horie M; Guan Z; Bei KF; Hwang DM; Liu M; Keshavjee S; Juvet SC
    Am J Transplant; 2019 Dec; 19(12):3377-3389. PubMed ID: 31365766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic Lung Allograft Dysfunction.
    Venado A; Kukreja J; Greenland JR
    Thorac Surg Clin; 2022 May; 32(2):231-242. PubMed ID: 35512941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of early pulmonary function changes after onset of chronic lung allograft dysfunction.
    Todd JL; Neely ML; Finlen Copeland CA; Frankel CW; Reynolds JM; Palmer SM
    J Heart Lung Transplant; 2019 Feb; 38(2):184-193. PubMed ID: 30466803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapy options for chronic lung allograft dysfunction-bronchiolitis obliterans syndrome following first-line immunosuppressive strategies: A systematic review.
    Benden C; Haughton M; Leonard S; Huber LC
    J Heart Lung Transplant; 2017 Sep; 36(9):921-933. PubMed ID: 28662986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update in Chronic Lung Allograft Dysfunction.
    Shah RJ; Diamond JM
    Clin Chest Med; 2017 Dec; 38(4):677-692. PubMed ID: 29128018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Humoral immunity in phenotypes of chronic lung allograft dysfunction: A broncho-alveolar lavage fluid analysis.
    Vandermeulen E; Verleden SE; Bellon H; Ruttens D; Lammertyn E; Claes S; Vandooren J; Ugarte-Berzal E; Schols D; Emonds MP; Van Raemdonck DE; Opdenakker G; Verleden GM; Vos R; Vanaudenaerde BM
    Transpl Immunol; 2016 Sep; 38():27-32. PubMed ID: 27561239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor Batf3 inhibits murine lung allograft rejection and airway fibrosis.
    Watanabe T; Lam C; Oliver J; Oishi H; Teskey G; Beber S; Boonstra K; Mauricio Umaña J; Buhari H; Joe B; Guan Z; Horie M; Keshavjee S; Martinu T; Juvet SC
    Mucosal Immunol; 2023 Apr; 16(2):104-120. PubMed ID: 36842540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.